| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027420588 |
| P356 | DOI | 10.1186/2194-7511-1-26 |
| P932 | PMC publication ID | 4215816 |
| P698 | PubMed publication ID | 25505689 |
| P5875 | ResearchGate publication ID | 269720811 |
| P50 | author | Peter C. Whybrow | Q2074257 |
| Paul Grof | Q91476141 | ||
| Emanuel Severus | Q100296720 | ||
| Ute Lewitzka | Q100416751 | ||
| Rita Bauer | Q107575964 | ||
| Tasha Glenn | Q114369954 | ||
| Kemal Sagduyu | Q114369971 | ||
| Michael Bauer | Q56953337 | ||
| P2093 | author name string | Greg Murray | |
| Martin Alda | |||
| Philipp Ritter | |||
| Rodrigo Munoz | |||
| Wendy Marsh | |||
| P2860 | cites work | Interventions for enhancing medication adherence | Q24243296 |
| Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States | Q24657307 | ||
| Clinical factors associated with treatment noncompliance in euthymic bipolar patients | Q28138392 | ||
| Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 | ||
| Antidepressant discontinuation syndromes | Q28188383 | ||
| The impact of medication regimen factors on adherence to chronic treatment: a review of literature | Q30436145 | ||
| Physician communication and patient adherence to treatment: a meta-analysis | Q30489604 | ||
| Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP | Q30569917 | ||
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders | Q30583384 | ||
| A systematic review of the associations between dose regimens and medication compliance | Q30719289 | ||
| Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data | Q30878126 | ||
| A regularity statistic for medical data analysis | Q31109894 | ||
| Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. | Q31112370 | ||
| Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? | Q33942947 | ||
| Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence | Q33974684 | ||
| Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder | Q34052836 | ||
| Factors that affect adherence to bipolar disorder treatments: a stated-preference approach | Q80362225 | ||
| Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk | Q80794891 | ||
| The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting. | Q51360835 | ||
| Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. | Q51850232 | ||
| Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. | Q51951722 | ||
| Risks and implications of interrupting maintenance psychotropic drug therapy. | Q52020833 | ||
| Hormone pulsatility discrimination via coarse and short time sampling. | Q52136743 | ||
| Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. | Q52888569 | ||
| The meaning of medications: another look at compliance | Q70065687 | ||
| Chronobiology. Suggestions for integrating it into drug development | Q70122466 | ||
| Factors associated with pharmacologic noncompliance in patients with mania | Q71151102 | ||
| Pharmacodynamics of variable patient compliance: implications for pharmaceutical value | Q73850406 | ||
| 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode | Q74541226 | ||
| [Compliance with and tolerance of sustained-release lithium carbonate] | Q77888267 | ||
| Pill taking ‘routinization’: a critical factor to understanding episodic medication adherence | Q79294050 | ||
| Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 | ||
| National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
| Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. | Q34098311 | ||
| Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany | Q34165024 | ||
| Brief depressive symptoms in patients with bipolar disorder: analysis of long-term self-reported data | Q34317237 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Treatment non-adherence in affective disorders. | Q34592227 | ||
| Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence | Q34597937 | ||
| Illness risk following rapid versus gradual discontinuation of antidepressants | Q34619690 | ||
| Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial | Q34748493 | ||
| Effect of medication dosing frequency on adherence in chronic diseases. | Q34985952 | ||
| The impact of reducing dose frequency on health outcomes | Q35544762 | ||
| The concordance of self-report with other measures of medication adherence: a summary of the literature | Q35814893 | ||
| Psychiatric and medical comorbidities of bipolar disorder | Q36021272 | ||
| The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses | Q36055586 | ||
| Resisting medicines: a synthesis of qualitative studies of medicine taking | Q36105011 | ||
| Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks | Q37283773 | ||
| Comparison of drug adherence rates among patients with seven different medical conditions. | Q37331773 | ||
| Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic | Q37352409 | ||
| Measurement of psychiatric treatment adherence | Q37594717 | ||
| Enhancing medication adherence in patients with bipolar disorder | Q37664710 | ||
| Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices | Q37809838 | ||
| Determinants of adherence to treatment in bipolar disorder: a comprehensive review | Q38089269 | ||
| Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. | Q38383710 | ||
| Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort | Q38452790 | ||
| Patient-level medication regimen complexity across populations with chronic disease. | Q39442718 | ||
| Non-adherence with psychotropic medications in the general population | Q39880242 | ||
| Factors associated with treatment nonadherence among US bipolar disorder patients | Q40146888 | ||
| The electronic medication event monitor. Lessons for pharmacotherapy | Q41478137 | ||
| Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey | Q43751280 | ||
| Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment | Q44102757 | ||
| Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. | Q44237722 | ||
| Burden of general medical conditions among individuals with bipolar disorder | Q45070754 | ||
| Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania | Q45154142 | ||
| Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics | Q46614706 | ||
| Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy | Q46704613 | ||
| Regularity in daily mood stabilizer dosage taken by patients with bipolar disorder | Q48458144 | ||
| Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder | Q48600493 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 26 | |
| P577 | publication date | 2013-12-09 | |
| P1433 | published in | International journal of bipolar disorders | Q27725397 |
| P1476 | title | Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity | |
| P478 | volume | 1 |
| Q28602477 | Big data are coming to psychiatry: a general introduction |
| Q26749257 | Big data for bipolar disorder |
| Q35671034 | Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study |
| Q64328434 | Comparison of Efficiency GEE and QIF Methods for Predicting Factors Affecting on Bipolar I Disorder Under Complete-case in a Longitudinal Studies |
| Q33446237 | Daily mood monitoring of symptoms using smartphones in bipolar disorder: A pilot study assessing the feasibility of ecological momentary assessment |
| Q28078940 | Electronic monitoring of self-reported mood: the return of the subjective? |
| Q26751363 | Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review |
| Q88527763 | Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder |
Search more.